Revati Shreeniwas
President at Revati, Inc.
Revati Shreeniwas active positions
| Companies | Position | Start | End |
|---|---|---|---|
Continuing Medical Education, Inc.
 Continuing Medical Education, Inc. Publishing: Books/MagazinesConsumer Services Continuing Medical Education, Inc. is based in San Diego, CA. Part of The Nielsen Company (US) LLC, Continuing Medical Education, Inc. is a company that publishes medical magazines and journals. Continuing Medical Education was acquired by Miller Freeman, Inc., part of The Nielsen Company (US) LLC from July 18, 2000 on March 26, 1999 for $111 million. | Corporate Officer/Principal | - | - |
| Revati, Inc. | President | 2003-12-31 | - |
Career history of Revati Shreeniwas
Former positions of Revati Shreeniwas
| Companies | Position | Start | End |
|---|---|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Chief Tech/Sci/R&D Officer | 2020-06-04 | 2022-11-30 |
| SOLENO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2019-10-31 | 2020-05-31 |
NeurAxon Pharma, Inc.
 NeurAxon Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon Pharma, Inc. researches and develops nervous system disorder therapies. The company is headquartered in Mississauga, Canada. | Chief Tech/Sci/R&D Officer | 2014-12-31 | 2016-12-31 |
| Stanford University | Corporate Officer/Principal | - | - |
| The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - | - |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Corporate Officer/Principal | - | - |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Corporate Officer/Principal | - | - |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
Statistics
International
| United States | 10 |
| Canada | 2 |
Operational
| Corporate Officer/Principal | 5 |
| Chief Tech/Sci/R&D Officer | 4 |
| President | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| SOLENO THERAPEUTICS, INC. | Health Technology |
| BRIGHT MINDS BIOSCIENCES INC. | Health Technology |
| Private companies | 6 |
|---|---|
Alvine Pharmaceuticals, Inc.
 Alvine Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Alvine Pharmaceuticals, Inc. develops and commercializes therapeutics for inflammatory diseases. It offers ALV003, tTG Inihibitors and HLA-DQ2 Blockers. The company was founded by Blair Stewart and Kevin R. Kaster in 2005 and is headquartered in San Carlos, CA. | Health Technology |
Continuing Medical Education, Inc.
Continuing Medical Education, Inc. Publishing: Books/MagazinesConsumer Services Continuing Medical Education, Inc. is based in San Diego, CA. Part of The Nielsen Company (US) LLC, Continuing Medical Education, Inc. is a company that publishes medical magazines and journals. Continuing Medical Education was acquired by Miller Freeman, Inc., part of The Nielsen Company (US) LLC from July 18, 2000 on March 26, 1999 for $111 million. | Consumer Services |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
| Revati, Inc. | |
NeurAxon Pharma, Inc.
NeurAxon Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon Pharma, Inc. researches and develops nervous system disorder therapies. The company is headquartered in Mississauga, Canada. | Commercial Services |
- Stock Market
- Insiders
- Revati Shreeniwas
- Experience
